Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis
Zobair M. Younossi, Linda Henry
Endocrine Practice (2021) Vol. 28, Iss. 2, pp. 204-213
Closed Access | Times Cited: 24

Showing 24 citing articles:

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Michael H. Le, Yee Hui Yeo, Biyao Zou, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 841-850
Open Access | Times Cited: 161
Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review
Hafiza Madiha Jaffar, Fahad Al‐Asmari, Faima Atta Khan, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 5, pp. 3097-3111
Open Access | Times Cited: 18
Genetics, epigenetics and transgenerational transmission of obesity in children
Nadia Panera, Claudia Mandato, Annalisa Crudele, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 38
Nonalcoholic Fatty Liver Disease
Scott Isaacs
Endocrinology and Metabolism Clinics of North America (2022) Vol. 52, Iss. 1, pp. 149-164
Closed Access | Times Cited: 38
The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progression
Giorgia Benegiamo, Giacomo von Alvensleben, Sandra Rodríguez-López, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 4
Open Access | Times Cited: 30
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions
M H Miran Beygi, Salma Ahi, Samaneh Zolghadri, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2220-2220
Open Access | Times Cited: 13
Research Priorities for Precision Medicine in NAFLD
Paula Iruzubieta, Ramón Bataller, M. Arias, et al.
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 535-551
Open Access | Times Cited: 12
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease
Jeffrey V. Lazarus, Marcela Villota‐Rivas, Carolina Jiménez-González, et al.
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 515-533
Closed Access | Times Cited: 9
FXR activation remodels hepatic and intestinal transcriptional landscapes in metabolic dysfunction-associated steatohepatitis
Yingquan Wen, Zi-Yuan Zou, Guanguan Zhao, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 11, pp. 2313-2327
Closed Access | Times Cited: 3
Budget impact of resmetirom for the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)
Jesse Fishman, Yestle Kim, Hélène Parisé, et al.
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 1108-1118
Open Access | Times Cited: 3
Estimation of the Eligible Population For Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis
Jesse Fishman, Yestle Kim, Michael Charlton, et al.
Advances in Therapy (2024) Vol. 41, Iss. 11, pp. 4172-4190
Open Access | Times Cited: 2
Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis
Xinzhu Liu, Jiaxuan Wang, Maogang Li, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 8, pp. 1438-1446
Open Access | Times Cited: 6
Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice
Sangam Rajak, Archana Tewari, Sana Raza, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 4, pp. 166662-166662
Open Access | Times Cited: 5
FPS-ZM1 attenuates the deposition of lipid in the liver of diabetic mice by sterol regulatory element binding protein-1c
Mengshu Zhang, Wanwan Zhao, Zhen Zhang, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Progression from Non-alcoholic Steatohepatitis to Advanced Liver Diseases and Mortality Among Medicare Patients
Yestle Kim, Joe Medicis, Matthew R Davis, et al.
Advances in Therapy (2024) Vol. 41, Iss. 11, pp. 4335-4355
Open Access | Times Cited: 1
Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice
Volodymyr Tryndyak, Rose Willett, Suresh K. Nagumalli, et al.
AJP Gastrointestinal and Liver Physiology (2023) Vol. 324, Iss. 3, pp. G232-G243
Open Access | Times Cited: 3
Compensated Advanced Chronic Liver Disease and Steatosis in Patients with Type 2 Diabetes as Assessed through Shear Wave Measurements and Attenuation Measurements
Mislav Barišić Jaman, Marko Milošević, Viktoria Škurla, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 323-323
Open Access
Tip 2 Diabetes Mellitus Tanılı Hastalarda Nonalkolik Yağlı Karaciğer Hastalığının Diabetin Süresi ve Diabetin Kronik Komplikasyonları İle İlişkisinin Değerlendirilmesi
Tuğba Kahraman Denizhan, Ahmet Kaya
Medical Journal of Western Black Sea (2024) Vol. 8, Iss. 3, pp. 314-322
Open Access
Genetic variation and elevated liver enzymes during childhood, adolescence and early adulthood
Stefan Stender, George Davey Smith, Tom G. Richardson
International Journal of Epidemiology (2023) Vol. 52, Iss. 5, pp. 1341-1349
Open Access | Times Cited: 1
Comparison of Pathway Referrals for Liver Fibrosis Risk Stratification Performed in Diabetology and Nutrition Clinics
Cyrielle Caussy, Charlène Telliam, Bader Al-Nuaimi, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1721-1729
Open Access | Times Cited: 1
Perspectives With Highlights of the 2021 American Association of Clinical Endocrinology Cardiometabolic Conference
Dace Trence, Armand Krikorian
Endocrine Practice (2022) Vol. 28, Iss. 2, pp. 127-128
Closed Access | Times Cited: 1
The social isolation enforced by the COVID-19 pandemic reduces the Health-Related Quality of Life score in the adult population of Metropolitan Lima, Peru
Valeria C. Morales-Ancajima, Cinthya Vásquez‐Velásquez, Melany De la Cruz, et al.
F1000Research (2023) Vol. 11, pp. 415-415
Open Access
Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A General Overview and Approach in Clinical Practice
Nwe Ni Than
Medical Research Archives (2023) Vol. 11, Iss. 11
Open Access
The social isolation enforced by the COVID-19 pandemic reduces the Health-Related Quality of Life score in the adult population of Metropolitan Lima, Peru
Valeria C. Morales-Ancajima, Cinthya Vásquez‐Velásquez, Melany De la Cruz, et al.
F1000Research (2022) Vol. 11, pp. 415-415
Open Access
Page 1

Scroll to top